
About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportGuiding and supporting the commercialization of cell and gene therapies.
In the complex world of cell and gene therapy (CGT), inefficiencies in communication, responsiveness and workflow consistency can delay patient access to critical treatments. InspiroGene by McKesson was created to solve these challenges by elevating the therapy experience at every touchpoint.
As an enduring ally, InspiroGene is dedicated to ensuring that patients receive the life-changing treatments they need. Through a thoughtfully designed, configurable approach, InspiroGene streamlines communication, enhances responsiveness and fosters a cohesive, consistent workflow for optimal patient outcomes.
Our suite of services includes:
Our high-touch services are designed to enhance patient outcomes, mitigate financial burdens and generate data to drive sustainable success.
100+
Our portfolio includes more than 100 clinical trials for cell and gene therapy products.
200+
We support more than 200 therapies in leading CGT indications of rare diseases and oncology.
95%
We provide services to 95% of active GT sites of care.
Our 2024 Cell and Gene Therapy Report reviews where CGT stands today and its future trajectory while exploring pain points.
Stay up to date on the latest from InspiroGene by McKesson.
InspiroGene is working to expand access to cell and gene therapy treatments to improve patient outcomes.
Learn more about how McKesson is advancing oncology and specialty care.
InspiroGene brings deep experience to the cell and gene therapy commercialization journey with established solutions to address the complex challenges of bringing these advanced therapies to market.
Learn more about how McKesson is advancing biopharma solutions.